Speaker illustration

Doctor Robert Mentz

Duke University Medical Center, Durham (United States of America)

Heart Failure Cardiologist and Clinical Trialist at Duke University Medical Center and the Duke Clinical Research Institute. Chief of the HF Section at Duke. Editor in Chief of the Journal of Cardiac Failure - the Official Journal of the HFSA

Ask the Trialist - HEART-FID

Event: ESC Congress 2023

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Ask the Trialists from Hot Line 2

Thumbnail

HEART-FID: Ferric Carboxymaltose in Heart Failure with Iron Deficiency

Event: ESC Congress 2023

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: HOT LINE 2

Thumbnail

Interactive panel discussion

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session: Two decades of research on iron deficiency in heart failure: looking back and moving forward

Thumbnail

Moving forward - knowledge gaps and ongoing trials

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session: Two decades of research on iron deficiency in heart failure: looking back and moving forward

Thumbnail

PARAGLIDEHF: Sacubitril/Valsartan versus valsartan on changes in NTproBNP, safety, and tolerability in patients with EF>40% stabilized after a WHF Event

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Late breaking clinical trials: medical therapy

Thumbnail

Fundamentals in iron deficiency and IV iron

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session: IV iron: the story so far

Thumbnail

Clinical outcome predictions for the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) trial

Event: Heart Failure 2021

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic Heart Failure - Pathophysiology and Mechanisms 2

Thumbnail

Effects of once-weekly exenatide on clinical outcomes in the subgroup of patients with pre-existing cardiovascular disease: insights from EXSCEL

Event: ESC Congress 2018

Topic: Clinical

Session: Management of coronary disease: temporal trends and residual risk

Thumbnail

Targeting the heart and associated comorbidities in HF.

Event: Heart Failure 2018

Topic: Clinical

Session: Expanding the evidence in heart failure patients

Thumbnail

Exploring new frontiers: is it time for a comorbidity-based approach in heart failure?

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Co-morbidities

Session: Management of co-morbidities in heart failure - Exploring new frontiers

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb